MODERNA SUES PFIZER AND BIONTECH FOR INFRINGING PATENTS CENTRAL TO MODERNA’S INNOVATIVE MRNA TECHNOLOGY PLATFORM Read more
Dupixent (dupilumab) approved by FDA as the first and only treatment indicated for prurigo nodularis Read more
Thermo Fisher Scientific Launches a More Sustainable Solution for Large-Scale Cell Culture Harvesting Read more
Verismo Therapeutics Receives FDA Orphan Drug Designation for SynKIR-110, a First-in-Class KIR-CAR T Cell Immunotherapy Candidate, for the Treatment of Mesothelioma Read more
Pheon Therapeutics Launches with $68 Million in Financing to Advance Novel Antibody-Drug Conjugates for Treatment of Solid Tumors Read more
Visus Therapeutics Expands Ophthalmic Drug Development Portfolio With Acquisition of ViewPoint Therapeutics’ Assets Read more
Arsenal Biosciences Announces Joint Discovery Collaboration with Genentech to Identify Features of Successful T-Cell Therapies for Oncology Read more
Koselugo approved in Japan for paediatric patients with plexiform neurofibromas in neurofibromatosis type 1 Read more